Company profile

Ticker
TEVA
Exchange
Website
CEO
Kåre Schultz
Employees
Incorporated
Location
Fiscal year end
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
SEC CIK

TEVA stock data

(
)

Calendar

5 Nov 20
5 Dec 20
31 Dec 20

News

Quarter (USD) Sep 20 Jun 20 Mar 20 Sep 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
3 Nov 20 Kare Schultz Ordinary Shares Option exercise Aquire M No 0 212,314 0 482,794
3 Nov 20 Kare Schultz Restricted Share Units Ordinary Shares Option exercise Dispose M No 0 212,314 0 0
1 Nov 20 Kare Schultz Ordinary Shares Option exercise Aquire M No 0 180,000 0 270,480
1 Nov 20 Kare Schultz Restricted Share Units Ordinary Shares Option exercise Dispose M No 0 180,000 0 296,389
9 Sep 20 Richard Daniell Ordinary Shares Sell Dispose S Yes 8.9844 333 2.99K 10,765
9 Sep 20 Richard Daniell Ordinary Shares Option exercise Aquire M No 0 698 0 11,098
9 Sep 20 Richard Daniell Restricted Share Units Ordinary Shares Option exercise Dispose M No 0 698 0 0
2 Sep 20 Abbas Hussain Restricted Share Units Ordinary Shares Grant Aquire A No 0 13,050 0 13,050
11 Aug 20 Crane Rosemary A Ordinary Shares Sell Dispose S No 11.9013 2,860 34.04K 33,509
11 Aug 20 Crane Rosemary A Ordinary Shares Option exercise Aquire M No 0 7,956 0 36,369
51.1% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 431 448 -3.8%
Opened positions 52 58 -10.3%
Closed positions 69 64 +7.8%
Increased positions 121 127 -4.7%
Reduced positions 141 143 -1.4%
13F shares
Current Prev Q Change
Total value 38.3B 48.99B -21.8%
Total shares 558.29M 577.38M -3.3%
Total puts 18.49M 21.53M -14.1%
Total calls 15.04M 21.7M -30.7%
Total put/call ratio 1.2 1.0 +23.8%
Largest owners
Shares Value Change
Capital Research Global Investors 130.11M $1.17B -0.0%
Capital World Investors 52.81M $475.78M +21.6%
BRK.A Berkshire Hathaway Inc. - 42.79M $385.53M 0.0%
BLK Blackrock 38.01M $342.45M +1.0%
Abrams Capital Management 24.05M $216.66M 0.0%
Capital International Investors 23.41M $210.95M +14.2%
Migdal Insurance & Financial 17.49M $157.55M -20.1%
STT State Street 16.48M $148.5M +5.2%
Clal Insurance Enterprises 13.91M $125.32M -15.3%
Menora Mivtachim 13.34M $120.19M -25.6%
Largest transactions
Shares Bought/sold Change
Capital World Investors 52.81M +9.38M +21.6%
FMR 30.76K -8.14M -99.6%
Ion Asset Management 0 -5.18M EXIT
Menora Mivtachim 13.34M -4.59M -25.6%
Migdal Insurance & Financial 17.49M -4.39M -20.1%
Psagot Investment House 4.49M +4.13M +1153.3%
Susquehanna International 4.5M -3.14M -41.1%
Noked Capital 0 -2.96M EXIT
Noked Israel 0 -2.96M EXIT
Renaissance Technologies 1.14M -2.95M -72.2%
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: ActavisGenericsthat, added, adolescent, adult, aforementioned, AirDuo, andproducing, andthose, anincome, Apixaban, Appendix, ArmonAir, Ascorbate, Ascorbic, Atripla, beennamed, Brazilian, breathing, Bystolic, bythe, Canadamay, Carbamazepine, Chloride, Clotrimazole, Committee, conviction, core, Cream, customary, debarment, deceleration, decreesat, Dimethyl, disoproxil, distancing, efavirenz, emtricitabine, en, endpoint, Etodolac, evidence, expensesand, Fluocinonide, fluticasone, gathered, guilty, HIV, holding, hospital, Imiquimod, indicted, indictment, influence, inNovember, intention, judge, krona, lira, magistrate, millionrelated, MoviPrep, Nadolol, nebivolol, negotiate, neuropsychiatry, ofadoption, ofArmonAir, ofSeptember, Ointment, Pa, pled, Potassium, Pravastatin, progression, propionate, proven, Proxy, recommendation, recommended, reconciling, referencedabove, reinstated, relaunch, relieve, restructuringand, salmeterol, Sherman, social, Sodium, strength, Subplan, Subtopic, sudden, sustainability, Swedish, taxexpense, Temozolomide, tenofovir, theearlier, theexpected, timeframe, Tobramycin, Truvada, Turkish, Warfarin, wasapproved, wave, wheezing, Yorkcommenced, Zyclara
Removed: conform, creditable, epinephrine, injection, IP, lack, Penalty, permitted, permitting, proceeded, producing, receipt, refundable, sector, similarly, situated, stipulated, TriCor